Polyamyna Nanotech Inc.: federal grants and contributions: 15 agreements; $2.7M value; 3 departments; 9 programs.
Assay record ASY-CA-0O2BE1R0IU · Cite as: Assay Systems, “Polyamyna Nanotech Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/polyamyna-nanotech-inc/
Support commercialization activities for an innovative antimicrobial coating technology
Undertake activities in support of commercialization of antimicrobial coatings technology
This project is to design and synthesize robust, inexpensive and long-lasting non-toxic antimicrobial coatings and additives that can be used effectively against multi-drug and pan-drug resistant bacteria to prevent healthcare-associated infections..
Processing of scaling-up production from a benchtop, lab-scale synthesis of product to a large, full-scale commercial manufacturing process for KeepKlear Antimicrobial Transparent Coating Materials.
Keep Klear is the first technology of its kind to be approved for clinical research trials in Canada, which is set to take place with Eastern Health. The clinical research trial is divided into 3 phases, where this innovative microbicidal technology is subjected to diversified test conditions to understand (a) its integration (b) its effectiveness (c) its impact on patient outcomes/readmissions.
To evaluate the efficacy of its innovative anti-mold coating in real-world environments.
Enhance business development capabilities to support commercialization efforts
Enhance technical capabilities to support company growth
Enhance commercialization management capabilities to support revenue growth
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
The Project will support development of intellectual property capacity within the Firm.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The purpose of the Canadian International Innovation Program (CIIP) grant agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
The purpose of this Canadian International Innovation Program (CIIP) contribution agreement is to support organizations and to identify specific projects or partnerships between the Recipient and international partners in CIIP target countries that could lead to industrial research and development cooperation with potential for commercialization.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.